
3 Ustekinumab Biosimilars Launch on US Market
After Wezlana (ustekinumab-auub) became the first ustekinumab biosimilar to enter the market in January 2025,1 3 others joined the fray, expanding access to lower-cost versions of blockbuster Stelara (ustekinumab).2-4 Samsung Bioepis/Sandoz, Biocon …